AABB first became involved in issues concerning hematopoietic progenitor cells (HPCs) in 1983 to update blood facilities about the special needs that bone marrow transplant patients have for hematologic support. As the field has evolved to include collection, processing, storage, and distribution of HPCs and other cell therapy products, AABB has expanded services to offer related programs in education, standards, and accreditation, along with numerous resources and reference tools. This section provides information on topics relating to cellular therapy as well as resources for the cellular therapy (CT) professional including materials developed by AABB CT subsections comprised of members from various professional backgrounds seeking to actively integrate the needs of the dynamic CT community.
Topics of Interest
ISBT 128 for CT Facilities Webinar Handout (PDF)
CLIA and Cellular Therapy Laboratories – Frequently Asked Questions
Regulatory Documents: Impact Analysis
Practice Snapshots
ISBT 128 for Cellular Therapy
Cellular Therapies Section
Cellular Therapies Section
Cellular Therapies Subsections
Cellular Therapies Subsections Projects
Meetings and Collaborations
FDA Liaison Meeting 10/21/10
Past Meetings
Alliance for Harmonization of Cellular Therapy Accreditation
Biopreservation Research Consortium
Cord Blood Licensure Workshop